A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 19,920 shares of BSX stock, worth $1.81 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
19,920
Previous 33,110 39.84%
Holding current value
$1.81 Million
Previous $1.47 Million 49.39%
% of portfolio
0.09%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$35.24 - $47.1 $464,815 - $621,249
-13,190 Reduced 39.84%
19,920 $742,000
Q1 2022

May 09, 2022

SELL
$40.9 - $45.1 $104,295 - $115,005
-2,550 Reduced 7.15%
33,110 $1.47 Million
Q4 2021

Jan 10, 2022

BUY
$38.07 - $44.87 $1.36 Million - $1.6 Million
35,660 New
35,660 $1.52 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.